Parx Plastics N.V. [ticker: MLPRX, ISIN: NL0012650535] holds an innovative patented technology to create antimicrobial plastics. The green chemistry invention is derived from biomimicry and is not using any harmful substances such as (nano-)silver, biocides, pesticides or nano-particles. Parx makes use of a biocompatible and bodily own trace element and incorporates it into the polymer without the chances of migration. The technology is not leaching out. The technology is safe to be used for food contact materials where it can prolong the shelf life of food and prevent contamination. It is also suitable to be used for medical devices and implants to reduce chances of infections. The technology is biocompatible, non-toxic, does not migrate, lasts a lifetime and reduces bacteria up to 99% measured according to ISO 22196
Parx Plastics N.V. [ticker: MLPRX, ISIN: NL0012650535] holds an innovative patented technology to create antimicrobial plastics. The green chemistry invention is derived from biomimicry and is not using any harmful substances such as (nano-)silver, biocides, pesticides or nano-particles. Parx makes use of a biocompatible and bodily own trace element and incorporates it into the polymer without the chances of migration. The technology is not leaching out. The technology is safe to be used for food contact materials where it can prolong the shelf life of food and prevent contamination. It is also suitable to be used for medical devices and implants to reduce chances of infections. The technology is biocompatible, non-toxic, does not migrate, lasts a lifetime and reduces bacteria up to 99% measured according to ISO 22196
Company Information
- Industry
- Plastics
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- Stationsplein 45 South Holland Rotterdam
- City
- Rotterdam
- Region
- Zuid-Holland
- Postal Code
- 3013
- Country
- Netherlands